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Vesicle trafﬁckingAn interaction between the Tobaccomosaic virus (TMV) 126 kDa replication protein and a host-encodedRabGDP
dissociation inhibitor (GDI2) was identiﬁed and investigated for its role in infection. GDI proteins are essential
components of vesicle trafﬁcking pathways. TMV infection alters the localization of GDI2 from the cytoplasm to
ER-associated complexes. Partial silencing of GDI2 results in signiﬁcant increases in the number of TMV infection
foci observed in inoculated tissues. However, GDI2 silencing does not affect TMV accumulation at the infection
site, cell-to-cell movement, or susceptibility of the host to mechanical inoculation. Furthermore, increases in the
number of successful infection foci were speciﬁc to TMV and correlated with the appearance of vesicle-like
rearrangements in the vacuolarmembrane. Tissue inﬁltrationswith brefeldinA, an inhibitor of vesicle trafﬁcking,
also enhanced host susceptibility to TMV. Combined these ﬁndings suggest that the 126 kDa–GDI2 interaction
alters vesicle trafﬁcking to enhance the establishment of an infection.f Maryland, College Park, MD
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
For simple positive-strand RNA viruses one essential step in the
establishment of an infection involves the association of replication-
associated components with elements of the host's endomembrane
system (Netherton et al., 2007; Miller and Krijnse-Locker, 2008).
The successful completion of this step is generally recognizable by
the formation of membrane associated virus replication complexes
(VRCs). While the form and cellular location of these membrane
complexes can vary dramatically between different viruses, they all
function to concentrate replication factors and mask nascent viral
RNA synthesis from cellular defenses. To date, a number of virus and
host components have been linked to the membrane rearrangements
associated with VRC assembly (Salonen et al., 2005; Netherton et al.,
2007; Miller and Krijnse-Locker, 2008). For example, the 3A protein
of Poliovirus, a member of the Picornaviridae, uses the GTPase cellular
secretory element Arf1 and its guanine exchange factor GBF1 to
selectively recruit phosphatidylinositol-4-kinase IIIβ, which catalyzes
the production of phosphatidylinositol-4-phosphate (PI4P) enriched
membrane lipids (Hsu et al., 2010). PI4P enriched membranes
subsequently attract the poliovirus 3D polymerase protein, initiating
VRC assembly and virus replication. In contrast, the 1a protein ofBromemosaic virus (BMV), type member of the Bromoviridae, contains
domains that include an amphipathic α-helix that mediate both
membrane and self interactions (Liu et al., 2009). The self-assembly of
1a is thought to produce a shell-like structure that combined with its
ability to associate with membranes produces the spherule-shaped
invaginations that are characteristic of the BMV VRC. From these
studies it is evident that the structural make-up and physiology of VRC
associated endomembrane systems are reprogrammed during infec-
tion. Knowledge as to how these endomembrane systems are altered
by the virus is thus essential to understanding the infection process.
In this study, we utilized Tobacco mosaic virus (TMV) as a model
positive-strand RNA virus to identify and investigate the role of a Rab
GDP dissociation inhibitor (GDI) in the establishment of infection.
TMV is the type member of the genus Tobamovirus and encodes
two replication proteins (126 and 183 kDa) as well as a coat protein
and movement protein (Goelet et al., 1982). Both replication proteins
contain methyltransferase and helicase domains. The 183 kDa
replication protein contains an additional RNA-dependent RNA-
polymerase domain that is produced via the read-through of an
amber stop codon at the end of the 126 kDa protein (Pelham, 1978).
Early in infection both 126 and 183 kDa proteins associate with the
endoplasmic reticulum (ER), forming small membrane associated
cytoplasmic VRCs (Heinlein et al., 1998; Mas and Beachy, 1999; dos
Reis Figueira et al., 2002). As the infection progresses these smaller
VRCs condense to form larger ER-derived membrane structures
known as viroplasms or X-bodies (Esau and Cronshaw, 1967; Hills
et al., 1987; Saito et al., 1987; Mas and Beachy, 1999). Evidence
Fig. 1. Interaction between the TMV126 kDa replication protein andGDI2. (A) Quantitative
β-galactosidase assays displaying an interaction between the 126 kDa helicase domain (a.a.
814–1116) and the GDI proteins from Arabidopsis (AtGDI2), N. tabacum (NtGDI2),
N. benthamiana (NbGDI2) and tomato (LeGDI2). The ethylene receptor component ETR1
is used as a non-interacting control. (B) Co-immunoprecipitation of AtGDI2-HA and the full-
length TMV 126 kDa replication protein within TMV-infected tissues.
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for the formation of these bodies as its expression alone results in the
formation of both early and late stage VRC-like cytoplasmic bodies
(dos Reis Figueira et al., 2002; Wang et al., 2010). Association of the
126 kDa replication protein with the hosts endomembrane system is
thought to occur via an interaction with the transmembrane protein,
TOM-1 (tobamovirus multiplication 1) (Yamanaka et al., 2000). TOM-
1 and the closely related TOM-3 protein are required for virus
replication and have been identiﬁed as possible membrane tethers for
replication complexes (Yamanaka et al., 2002). Interestingly, TOM
proteins have been shown to predominantly localize to the plant cell
vacuolar membrane, suggesting that either these proteins localize
differently during infection or that the vacuolar membrane plays a
role in infection (Hagiwara et al., 2003).
Using a yeast two-hybrid approach we identiﬁed an interaction
between the helicase domain of the TMV 126 kDa protein and the
Arabidopsis encoded Rab GDP dissociation inhibitor protein 2 (GDI2).
GDI proteins regulate the activity of Rab proteins and are essential
components of vesicle trafﬁcking within the cell. Rab proteins are
members of the Ras superfamily of small GTPases that function to
regulate intracellular vesicle trafﬁcking pathways (Pfeffer, 2003; Barr,
2009). GDI proteins bind to Rab proteins in their inactive, GDP-bound
state and recycle them to their donor membrane for use in further
vesicle trafﬁcking (Seabra andWasmeier, 2004; Ali and Seabra, 2005).
There are 57 identiﬁed Rab proteins in Arabidopsis thaliana, but only
two identiﬁed GDI proteins (Bock et al., 2001; Pereira-Leal and Seabra,
2001). Both Arabidopsis GDI proteins share 95% identity and show
similarly high levels of identity with GDI proteins in tomato, 82%, and
tobacco, 84%. This level of homology suggests that these proteins are
functionally conserved within a range of TMV hosts.
Since GDI proteins play an essential role in vesicle trafﬁcking and
because TMV replication occurs on vesicle-like membrane bodies, the
interaction between GDI2 and the TMV 126 kDa replication protein
was further investigated. Studies revealed that TMV infection alters
the localization of GDI2 from the cytoplasm to ER-associated
membrane bodies of similar size and shape to those produced during
infection. Interestingly, silencing GDI2 prior to infection signiﬁcantly
increased the number of TMV infection foci produced upon inocula-
tion, indicating that GDI2 regulates factors involved in host suscep-
tibility. This enhanced susceptibility was speciﬁc to TMV and
correlated with the appearance of vesicle-like rearrangements in the
vacuolar membrane. Combined, these ﬁndings suggest that the TMV–
GDI2 interaction modulates factors within the cell's vesicle transport
system that contribute to the infection process.Results
Rab GDP dissociation inhibitor 2 (GDI2) interacts with the TMV 126 kDa
protein
The helicase domain of the TMV 126/183 kDa replication proteins,
amino acids 814–1116, was used in a two-hybrid assay to probe an
Arabidopsis thaliana ecotype Nossen cDNA library for replicase
interacting proteins. Of several interacting Arabidopsis clones, three
were found to encode the C-terminal 110 amino acids of AtGDI2
(At3g59920). To further conﬁrm this interaction the full-length 445
amino acid (49.5 kDa) AtGDI2 open reading frame (ORF) was cloned
from the highly TMV susceptible Arabidopsis ecotype Shahdara
(Dardick et al., 2000) and demonstrated via two-hybrid assay to
interact with the viral helicase domain (Fig. 1A). Subsequent sequence
comparisons revealed AtGDI2 shares signiﬁcant sequence identity
with GDIs found in other important TMV hosts including Solanum
lycopersicum (82%; TIGR gene index TC162880), Nicotiana tabacum
(84%), andNicotiana benthamiana (84%). Full-length GDIs cloned from
these hosts were also found to interact with the TMV helicase domainvia the two-hybrid assay (Fig. 1A), suggesting that this interaction is
conserved among diverse TMV hosts.
To conﬁrm the GDI2–TMV helicase interaction occurs within the
context of an infection the AtGDI2 ORFwas fused to the hemagglutinin
(HA) epitope and cloned into an Agrobacterium expression vector to
create p35S::HAAtGDI2. Agroinﬁltration of p35S::HAAtGDI2 into TMV
or mock infected leaf tissue was subjected to pull-down assays using
anti-HA antibodies. Results indicated that complexes containing
HAAtGDI2 and the full-length TMV 126 kDa replication protein were
recovered only from tissues that were both p35S::HAAtGDI2 inﬁl-
trated and TMV infected (Fig. 1B). Thus, HAAtGDI2 is capable of
interacting with the full-length 126 kDa replicase protein within the
context of an active virus infection.TMV infection alters AtGDI2-GFP localization
The effects of a TMV infection on the localization and accumula-
tion of GDI2 were investigated using 35S::AtGDI2-GFP transgenic
N. benthamiana plants expressing the AtGDI2 ORF fused to GFP.
Low magniﬁcation ﬂuorescent microscopy indicated that within un-
infected tissues AtGDI2-GFP ﬂuorescence is localized to the cytoplasm
of epidermal leaf cells (Fig. 2A). This is consistent with the localization
of related GDI proteins and their role in vesicle transport (Ullrich et al.,
1993; Seabra and Wasmeier, 2004). In contrast, we noted that within
TMV-infected tissues AtGDI2-GFP derived ﬂuorescence was substan-
tially altered, suggesting that infection changes either the localization
or accumulation of the AtGDI2-GFP protein (Fig. 2A). Western im-
munoblots for the detection of GFP were used to monitor the
accumulation of AtGDI2-GFP in both mock and TMV-infected tissues.
Analysis of two independent transgenic 35S::AtGDI2-GFP lines
indicated no noticeable difference in the accumulation of AtGDI2-
GFP in either mock or infected tissues (Fig. 2B). Higher magniﬁcation
confocal microscopy studies with the addition of Rhodamine B hexyl
ester, an ER/mitochondria stain (Rashid and Horobin, 1990; Terasaki
Fig. 2. TMV directed relocalization of AtGDI2-GFP. (A) Mock and TMV-infected
transgenic N. benthamiana expressing AtGDI2-GFP fusion protein. Both images were
taken with the same image settings. (B) Western immunoblots for the detection of
AtGDI2-GFP and the TMV coat protein (CP) from two independent 35S::AtGDI2-GFP
transgenic lines either mock or TMV infected. (C) Confocal microscopy image of mock
or TMV-infected 35S::AtGDI2-GFP transgenic leaf tissue with GFP or ER Rhodamine B
derived ﬂuorescence. Bars=10 μm.
Fig. 3. Effects of AtGDI2 over-accumulation on TMV infection. (A) Western
immunoblots for the detection of AtGDI2-GFP and TMV coat protein (CP) in 35S::
AtGDI2-GFP and non-transformed N. benthamiana plants. Lanes represent protein
levels in individual TMV30BdsRed ﬂuorescent infection foci at 8 dpi. (B) Number
of TMV30BdsRed infection foci in 35S::AtGDI-GFP transgenic and non-transgenic
N. benthamiana plants at 8 dpi. Data was taken from 10 different leaves on ﬁve different
plants. The t test value for the number of TMV30BdsRed infection foci is P(T≤ t)=0.15.
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GFP is predominantly relocalized to ER-associated inclusions (Fig. 2C)
similar to those that occur in response to a TMV infection or the
transient expression of the TMV 126 kDa replicase protein (Mas
and Beachy, 1999; dos Reis Figueira et al., 2002). Combined these
data indicate that TMV infection does not signiﬁcantly alter the
accumulation of AtGDI2-GFP protein but instead changes its cellular
localization.
Over-expression of AtGDI-GFP does not affect TMV infection
TMV induced disruptions in the localization of GDI2 suggest
that functions of this host protein play a role during virus infection.
To address this possibility transgenic 35S::AtGDI2-GFP plants were
used to investigate the effect of AtGDI2-GFP overexpression on TMV
infection. A recombinant TMV construct, TMV30BdsRed, expressing
the ﬂuorescent dsRed protein from a heterologous coat protein
subgenomic promoter was used to identify virus-infected tissues inthese plants (Shivprasad et al., 1999). TMV30BdsRed infection foci
were monitored for spread and TMV coat protein accumulation. In
comparison to non-transgenic control plants the appearance of
TMV30BdsRed infection foci were not signiﬁcantly altered in terms
of numbers or the accumulation of TMV coat protein (Fig. 3). This
suggests that over-accumulation of GDI prior to infection does not
signiﬁcantly alter the infection process.
Silencing of NbGDI2 enhances host susceptibility to TMV infection
A Tobacco rattle virus (TRV) gene silencing system was used as a
means to investigate GDI2 function during infection. TRV produces
mild symptoms in tobacco and tomato and has been developed as a
viral induced gene silencing (VIGS) vector to knockdown the ex-
pression of targeted endogenous genes (Dinesh-Kumar et al., 2003).
TRV-VIGS knockdown of the Nicotiana benthamiana NbGDI2 gene
resulted in a signiﬁcant reduction (N77%) in the level of NbGDI2
mRNA in comparison to a TRV vector only control construct (Fig. 4A).
NbGDI2 VIGS silenced plants produced characteristic mild TRV
symptoms indicating that the partial disruption of this gene was not
signiﬁcantly detrimental to cell survival. The number of expressed GDI
genes in N. benthamiana is unknown; however, based on the strong
sequence similarity between AtGDI1 and AtGDI2 (95%) it seems likely
that VIGS induced GDI silencing could disrupt the accumulation of all
related GDI sequences within N. benthamiana.
In initial studies, puriﬁed TMV30BGFP was mechanically inoculat-
ed onto 29 fully expanded leaves of 15 N. benthamiana plants infected
with the TRV NbGDI2 silencing construct and 29 leaves of 15 plants
infected with the unmodiﬁed TRV vector construct. The average
number of ﬂuorescent infection foci observed in the VIGS NbGDI-
silenced leaves (mean=81, SE=10) was signiﬁcantly more than that
of the infection foci observed in the vector only leaves (mean=29,
Fig. 4. Enhanced susceptibility to TMV30BGFP in NbGDI2-silenced leaf tissue. (A and D) Representative semiquantitative RT-PCR analysis of NbGDI2-silenced and control
N. benthamiana tissues. (B and E) Results of infectivity assays with TMV30BGFP in NbGDI2-silenced and control leaves. Photos taken at 8 dpi (B) and 9 dpi (C). (C and F) Number
of TMV30BGFP infection foci averaged from 29 (C) and 21 (F) leaves per treatment.
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measured as the average diameter of TMV30BGFP ﬂuorescent
infection foci, and virus accumulation, measured as the level of
detectable coat protein in individual TMV30BGFP foci, were found to
be similar for NbGDI-silenced and TRV vector control plants (data not
shown). Thus, the knockdown of NbGDI2 mRNA levels did not appear
to affect the biology of the virus once the initial infection was
established.
To further conﬁrm this observation a second VIGS control con-
struct that expresses a segment of the β-glucuronidase gene (GUS)
was created as a means to mimic any effect conferred by the addition
of a sequence to the TRV-VIGS vector. RT-PCR analysis of NbGDI2
mRNA again showed a signiﬁcant reduction in the NbGDI2 VIGS
silenced leaf tissue in comparison to tissue infected with the TRV-GUS
vector construct (Fig. 4D). We also monitored the level of TRV geno-
mic RNA present in both NbGDI2 and GUS TRV infected tissues and
found that neither the NbGDI2 sequence nor its silencing adversely
affected the accumulation of the TRV silencing vector (Fig. 4D). To
monitor TMV infections, two sets of 21 leaves from 10 N. benthamiana
plants infected with either the NbGDI2 or GUS TRV-VIGS constructs
were inoculated with TMV30BGFP. Results again demonstrated that
silencing of NbGDI2 produces a greater than 2-fold increase in
TMV30BGFP infection foci (mean=96, SE=12) over the control TRV-
GUS (mean=44, SE=6) (P(T≤ t)=4.45 × 10­4; Fig. 4E and F).
GDI silencing does not alter the efﬁciency of mechanical inoculations
One possible explanation for enhanced TMV susceptibility in GDI2
silenced tissues is that these tissues are simply easier to infect bymechanical wounding. In this hypothesis, GDI2 silencing affects
cellular membranes such that they are more susceptible to mechanical
inoculations or recover more slowly from wounding and thus remain
accessible to virus infection over a longer period of time. To test these
possibilitieswe ﬁrst determined if the enhanced susceptibility observed
in NbGDI2 silenced tissues was speciﬁc to TMV. For these experiments
NbGDI2 silenced leaf tissueswere challengedwith Tobacco necrosis virus
(TNV). TNV is a member of the Tombusviridae family of plant viruses
and shares no speciﬁc sequence homologies with TMV. TNV also
produces a distinctive necrotic lesion at the site of infection in leaves of
N. benthamiana making it possible to assess numbers of infection foci.
Results from TNV inoculations showed no signiﬁcant difference in the
number of TNV lesions observed in either NbGDI2 (mean=96, SE=4)
or GUS-silenced (mean=72, SE=10) plants (P(T≤ t)=0.37; Fig. 5A),
suggesting that the silencing of GDI2 is speciﬁc to TMV infection.
We also utilized a detached leaf assay to determine if NbGDI2
silenced tissues were slower to recover from mechanical wounding
(Furumoto andWildman, 1963). Speciﬁcally, detachedN. benthamiana
leaves were mechanically wounded by rubbing with carborundum
and at various times post-wounding inoculated by dipping into a
solution of 0.005 or 0.001 mg/ml of TMV30BGFP. Results showed
increased TMV30BGFP infection sites in NbGDI2 silenced leaves vs.
GUS-silenced control leaves (Fig. 5B). However, when the number of
infection sites at each time point is calculated as a percent of the total
infection sites produced at time zero no speciﬁc differences in the
overall rate of infectivity is observed between treatments (Fig. 5C).
Thus, recovery from mechanical wounding appears to occur equally
well in NbGDI2 silenced and non-silenced tissues. Combined these
ﬁndings indicate that alterations in host susceptibility to mechanical
Fig. 5. GDI silencing does not affect the efﬁciency of mechanical inoculations.
(A) Number of TNV infection foci observed in NbGDI2 silenced and control leaf tissues.
(B) Number of TMV30BGFP infection foci observed in silenced and control
N. benthamiana leaf tissues at times post-wounding. Leaves were wounded and then
immersed in a solution of 0.005 mg/ml or 0.001 mg/ml puriﬁed TMV30BGFP at the
speciﬁed time points. (C) Data in B presented as the percent of the total number of
infection foci observed at time zero for each treatment.
Fig. 6. Brefeldin A treatment enhances susceptibility to TMV30BGFP in N. benthamiana.
(A) DMSO only and DMSO plus 5 μg/ml brefeldin A (BFA) treated half leaf assay
inoculated with TMV30BGFP. (B) TMV30BGFP infection foci per half leaf averaged from
12 leaves.
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susceptibility observed in GDI2 silenced tissues.
Brefeldin A enhances susceptibility to TMV
Increased susceptibility to TMV in GDI2 silenced tissues could have
been linked tomembrane perturbations that enhanced the availabilityof host components needed to initiate VRC formation. Since GDI
proteins function in the recycling of proteins involved in vesicle
trafﬁcking, we reasoned that reductions of available GDI2 proteins
disrupt the transport of vesicles and their cargo within the cell. To test
this hypothesis we used the drug, brefeldin A (BFA) as an alternative
means to disrupt vesicle trafﬁcking. BFA targets the Sec7 domain
of guanine nucleotide exchange factors that activate the Arf family
of small GTPases involved in the regulation of vesicle transport.
Disruption of Arf function inhibits vesicle retrograde trafﬁcking from
the ER to the Golgi, affecting the distribution of components within
the endomembrane network (Klausner et al., 1992; Shin and
Nakayama, 2004). Half-leaf assays in which half of the leaf was
inﬁltrated with 1% DMSO and the other half of the leaf was inﬁltrated
with 1% DMSO containing 5 μg/ml of BFA were compared for
susceptibility to infection by TMV30BGFP. Within the leaf halves
treated with BFA we noted a 40% (P(Tb= t)=0.0089) increase in the
number of ﬂuorescent infection foci as compared to the DMSO only
inﬁltrated leaf half (Fig. 6). This ﬁnding suggests that interference in
the trafﬁcking of proteins within the endomembrane system, either
by disrupting GDI2 function or BFA treatment has a positive impact on
the establishment of TMV infection sites.
Silencing NbGDI2 produces endomembrane changes in the vacuolar
membrane similar to that observed during TMV infection
Since GDI proteins function in vesicle trafﬁcking and TMV is
known to remodel ER membranes during replication we reasoned
that TMV interference in GDI2 function may have a role in this
remodeling. To monitor changes to the endomembrane system,
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their target membranes and expressed as GFP fusion proteins. The
marker proteins selected were (GFP-HDEL [ER] (Haseloff et al., 1997),
GFP-Vam3 [vacuole] (Uemura et al., 2002), Sar1-GFP [ER exit site]
(daSilva et al., 2004), Pad1-GFP [20S proteosome] (Fu et al., 1998)
and ERD2-GFP [Golgi]. Using the TRV-VIGS system, transgenic
N. benthamiana lines for each of the GFP marker proteins were
silenced for NbGDI2 and examined by ﬂuorescence microscopy for
changes in the localization of the marker proteins in comparison to
TRV vector only treated plants.NbGDI2 silencing in ER (GFP-HDEL and
Sar1-GFP), proteosome (Pad1-GFP) or Golgi (ERD2-GFP) backgrounds
did not produce a noticeable difference in the localization or intensity
of GFP derived ﬂuorescence (Supplemental Fig. 1). In contrast,NbGDI2
silencing in vacuolar GFP-Vam3 plants resulted in the production of
small (3–9 μm) vesicle-like bodies (Fig. 7B and E). In Z-stacks these
bodies appeared to be distributed throughout the cytoplasm of the
cells (Supplemental Fig. 2). In contrast, control TRV vector only plants
did not display similar types of GFP-Vam3 vesicle-like bodies (Fig. 7A;
Supplemental Fig. 2). The appearance of GFP-Vam3 labeled vesicles
suggests that the transport of this vacuolar marker protein is altered
in response to NbGDI2 silencing.
Although TMV infection has not previously been shown to alter the
vacuolar membrane, the accumulation of Vam3 vesicle-like bodies in
GDI2-silenced tissues was of interest since the 126 kDa-interacting
TOM host proteins have been shown to predominantly localize to the
vacuolar membrane (Hagiwara et al., 2003). When we compared
TMV-infected and mock-inoculated GFP-Vam3 plants, we observed
discrete Vam3-GFP labeled vesicles similar to those observed in GDI2
silenced Vam3-GFP tissues (Fig. 7C and D). These ﬁndings suggest that
interference in GDI2 function, either by silencing or virus infection,
produces a similar effect on the vacuolar membrane system.
Discussion
For viruses, the cellular environment of the initially infected cell
represents an important determinant in the establishment of
infection. Within compatible hosts, the initiation of virus infection
generally occurs rapidly upon cell entry, suggesting that the cellular
components needed to establish an infectionmust be readily availableFig. 7. Effects of GDI silencing and TMV infection on the localization of the vacuolar marke
plants including the vector control, silenced for NbGDI2, mock-inoculated or infected with
analysis of NbGDI2-silenced and control tissues. (F) Western immunoblot for the detection o
tissues from two independent transgenic lines.and in sufﬁcient quantity prior to virus entry. In this study we
identiﬁed GDI2, a Rab GDP dissociation inhibitor protein, as a host
component thatmodulates cell susceptibility to the establishment of a
TMV infection. AtGDI2 can functionally replace the yeast GDI protein,
Sec19, and interact with speciﬁc Arabidopsis Rab proteins, demon-
strating that AtGDI2 is a functional Rab GDP dissociation inhibitor
protein (Ueda et al., 2006). Rab GDP dissociation inhibitor proteins
play essential roles in the regulation of numerous small Rab GTPase
proteins that in turn are involved in vesicle formation, vesicle
movement and membrane fusion, functions that are essential in the
intracellular trafﬁcking of proteins. The ability of TMV replication
proteins to interact with and disrupt GDI2 localization indicates
that virus infection alters vesicular trafﬁcking within the infected
cell. Furthermore, enhanced susceptibility to TMV infection in GDI2
silenced leaf tissues suggests a link between GDI2 directed cellular
trafﬁcking and the establishment of cellular conditions that favor
infection.
The establishment of a virus infection involves a series of steps. For
TMV the infection process ﬁrst requires cellular entry through
healable wounds caused by mechanical damage. Upon cellular entry
the higher pH and reduced calcium ion concentrations within the cell
result in the disassembly of the rod-shaped virion from the virus 5′
RNA end (Namba et al., 1989; Culver 2002). This exposes the 5′ end
CAP and ribosome initiation site within the virus RNA. Subsequent
translation results in the production of the 126/183 kDa replication
proteins that in turn recognizes the disassembled 3′ RNA end and
initiates minus strand RNA synthesis. Christensen et al. (2009) have
recently shown that microinjected ﬂuorescently labeled TMV RNA
forms distinct packets that rapidly associate with the motile cortical
actin/ER network within the cytoplasm. The 5′ RNA end CAP which
is required for infectivity was also required for formation of these
packets. This information suggests that the initial translation and
attachment of TMV to ER sites of replication occurs via a CAP
dependent translation process (Christensen et al., 2009). This is
consistent with other eukaryotic mRNAs that have been shown to
be localized to speciﬁc cell structures (Meignin and Davis, 2010).
To establish an active virus replication complex TMV replication
proteins must associate with the ER. Within Arabidopsis the mem-
brane spanning proteins TOM1 and 3 are required for efﬁcient virusr protein Vam3. (A–D), Confocal images of 35S::GFP-Vam3 transgenic N. benthamiana
TMV. Arrows in B and D indicate vesicle-like structures. (E) Semiquantitative RT-PCR
f the GFP-Vam3marker protein and the TMV coat protein (CP) in mock and infected leaf
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interact with the TMV 126/183 kDa replication proteins and are
thought to function as tethers, linking the viral replicase to host
endomembrane system (Yamanaka et al., 2000). The availability of
these components is therefore a critical link in establishing active
replication complexes.
Disruption of GDI2 function affected only the susceptibility of the
host to TMV infection and not TMV movement or virus accumulation
at the infection site. This ﬁnding suggests that GDI2 silencing alters
the availability of cellular components necessary to establish an
infection but does not represent a rate-limiting step once an infection
is initiated. Thus, the identiﬁed interaction between GDI2 and TMV
replication proteins most likely represents a mechanism to modulate
the composition of the host's endomembrane system during the
establishment of an infection. Rab GDP dissociation inhibitor proteins
are essential in the recycling and regulation of Rab proteins, affecting
an array of vesicle functions, including formation, docking and fusion.
Disruption of these functions is likely to affect the processing,
movement and localization of numerous host-encoded proteins via
the endomembrane system. One possible outcome of this disruption
could be alterations in vesicle and protein transport that result in the
cell's membranes becoming more susceptible to wounding via
mechanical inoculations. However, infectivity studies done at varying
time points post-wounding indicate that only the number of infection
sites increased in GDI2 silenced tissues but not the speciﬁc rate of
infectivity. This suggests that observed changes in cell susceptibility
are due to alterations in the ability of the virus to establish an infection
not in the ability of TMV to gain access to the cell. Additionally, GDI2
silencing did not affect the number of infection sites obtained via
mechanical inoculation of the non-related virus, TNV. Enhanced
susceptibility to TMV but not TNV further indicates that the effects
of silencing GDI2 are speciﬁc to TMV and not the result of general
changes in membrane properties.
Another possible explanation for enhanced TMV susceptibility
observed in GDI2 silenced tissues involves the reallocation of host
components needed to establish an infection. By altering the location
and/or concentration of needed host components TMV could increase
the probability that an infecting virus RNA can initiate an infection.
Previous studies have indicated that a minimum of ~72 virus particles
are needed to establish a TMV infection by microinjection (Halliwell
and Gazaway, 1975). Although these microinjection studies do not
rule out the possibility that one virus particle can cause an infection
they do suggest that not every particle entering a cell will always
establish an infection. Thus, access and availability to host compo-
nents required for replication likely play an important role in
establishing an infection. GDI2's role in vesicle transport would
suggest that interference in its function could alter the distribution of
host components needed for replication within the endomembrane
system. The ability of BFA treatments to similarly enhance suscepti-
bility to TMV provides additional support to indicate that alterations
in the composition of the endomembrane system brought on by the
disruption of normal vesicle trafﬁcking can enhance the ability of TMV
to establish an infection.
It is likely that disruption of vesicle trafﬁcking results in altered
distributions of numerous host proteins. Consistent with this
possibility we noted that GDI2 silencing enhanced the production
of small vesicle-like bodies in vacuolar labeled Vam3-GFP labeled
tissues. We also noted the enhanced production of similar Vam3-GFP
labeled bodies in TMV-infected tissues. Vam3 functions as a t-SNARE
protein on the surface of the vacuolar membrane and is thus involved
as a vesicle transport receptor (Sato et al., 1997). The observed Vam3-
GFP labeled bodies would suggest that in GDI2 silenced or TMV-
infected tissues the targeting of Vam3-GFP to the vacuolar membrane
or its maintenance within the vacuolar membrane is altered. To our
knowledge this is the ﬁrst report to identify TMV induced alterations
in a vacuolar marker protein. This is of interest since it has previouslybeen demonstrated that the identiﬁed replicase interacting mem-
brane protein TOM1 primarily localized to the vacuolar membrane
(Hagiwara et al., 2003). The predominant localization of TOM proteins
to the vacuolar membrane while TMV replication occurs on the ER
suggests that these proteins may be redirected or blocked in their
transport to the vacuolar membrane during infection. Disruption of
vesicular trafﬁcking through the disruption of GDI2 function could
provide a route for this to occur. However, additional studies tracking
changes in the localization of TOM proteins and other vacuolar
proteins are needed to conﬁrm this possibility.
Materials and methods
Plant material, virus constructs and infectivity analysis
All plants were grown in LCI potting mix (SunGro Inc., Bellevue,
WA) at 28 °C with a 12 h light/dark cycle and 80% humidity.
TMV30BGFP and TMV30BdsRed cDNA constructs contain the GFP
or dsRed ORF inserted downstream of the TMV coat protein
subgenomic promoter via PCR generated Pac1 and Xho1 restriction
sites (Shivprasad et al., 1999). TMV30BGFP and TMV30BdsRed virions
were puriﬁed from transcript infected plants as previously described
(Gooding and Hebert, 1967).
Virus infections were accomplished via rub inoculations of
carborundum dusted leaves using 20 μL of 0.5 mg/ml puriﬁed virions
for TMV30BGFP and 20 μL of 0.75 mg/ml of TMV30BdsRed. A Tobacco
necrosis virus (TNV) strain isolated by Dr. K. Corbett, University of
Maryland, was similarly inoculated using 20 μL of 0.025 mg/ml
puriﬁed virions. The time course infectivity analysis was performed
as previously described with the following modiﬁcations (Furumoto
and Wildman, 1963). Carborundum dusted detached N. benthamiana
leaves were rub wounded and then dipped at speciﬁc times post-
wounding in a 1 μg/ml or 5 μg/ml suspension of TMV30BGFP. Leaves
were keptmoist betweenwounding and inoculation times. Inoculated
leaves were kept in a humidity chamber prior to imaging for
ﬂuorescent infection foci at 6–8 days post-inoculation.
Yeast two-hybrid and in vivo pull-down assays
Yeast two-hybrid screens between an Arabidopsis ecotype Nossen
cDNA library (ABRC, Columbus, OH) and the TMV helicase domain,
amino acids 814–1116, were performed as previously described
(Padmanabhan et al., 2005). Full-length GDI2 ORFs were cloned into
the yeast vector pGAD10 from cDNA derived from Lycopersicon
esculentum cv Pilgrim, Arabidopsis thaliana ecotype Shahdara, Nicotiana
tabacum cvXanthi, andN. benthamiana via PCRgeneratedXhoI and EcoRI
restriction sites. Full-length pGAD-GDI2 clones were subsequently co-
transformed into yeast strain L40with either pLexA-Helicase, the empty
pLexA vector or one encoding an ethylene receptor component, ETR1
(Clark et al., 1998). Two-hybrid derived β-galactosidase activity was
quantiﬁed in liquid culture as previously described (Miller, 1972;
Goregaoker et al., 2001).
In vivo pull-down assays were performed as described (Wang
et al., 2009). Brieﬂy, the full-length cDNA of AtGDI2 was cloned
downstream of the double 35S promoter and fused via the C-terminus
to the hemagglutinin (HA) tag of the pPily cassette vector using PCR
generated BamHI and EcoRI restriction sites (Ferrando et al., 2000).
The pPily expression cassette was subsequently cloned into pBIN19-
Plus using a unique KpnI site to create pBINAtGDI2 and transformed
into Agrobacterium tumefaciens strain GV3101 (Holsters et al., 1978;
van Engelen et al., 1995; Ferrando et al., 2000). Leaves of
N. benthamiana were inoculated with 0.5 μg/ml of wild-type TMV
and at 2 days post-infection inﬁltrated with Agrobacterium carrying
the pBINAtGDI2. Leaf tissue was harvested and extracted in buffer
(50 mM Tris–HCl at pH 8.0, 150 mM NaCl, 0.5% TritonX-100, 0.2% 2-
mercaptoethanol, 5% glycerol) with the addition of 1 mM PMSF and
117S.R. Kramer et al. / Virology 414 (2011) 110–118proteinase inhibitor cocktail (Sigma, St. Louis, MO). Tissue extracts
were incubated overnight at 40 °C with 5 μL of anti-HA antibody
(Santa Cruz Biotechnologies) followed by an additional 3-h incubation
with protein A agarose (Invitrogen, Carlsbad, CA). Precipitated
immune complexes were resuspended in 2× Laemmli buffer and
separated by SDS-PAGE (Laemmli, 1970). Resolved proteins were
visualized via Western blot using HA and TMV replicase speciﬁc
antibodies.
GDI2 silencing assays
The Tobacco rattle virus VIGS vectors (pTRV1 and pTRV2) were
kindly provided by Dr. S. P. Dinesh-Kumar, University of California,
Davis (Liu et al., 2002). Nucleotides 888–1284 of NbGDI2 cDNA and
AtGDI2 cDNAwere PCR-modiﬁed to contain 5′ EcoR1 and 3′ KpnI sites,
ligated into similarly digested pTRV2 plasmids and transformed into
A. tumefaciens strain GV3101. Nucleotides 9–409 of theβ-glucoronidase
gene were similarly PCR ampliﬁed to contain unique EcoRI and KpnI
sites, ligated into the pTRV2 vector and transformed into the GV3101
strain. For VIGS assays, A. tumefaciens containing pTRV2:GDI2 or
pTRV2:GUS or the unmodiﬁed pTRV2 vector were mixed with an
equal volume of cells containing the pTRV1 vector and inﬁltrated into
N. benthamiana plants at the four leaf stage.
For mRNA analysis, total RNA was extracted as per the manufac-
turer's protocol using Trizol reagent (Invitrogen, Carlsbad, CA). One
microgram of total RNA was pretreated with RQ1 DNase (Promega,
Madison, WI) and then reverse-transcribed using the SuperScript®
First-Strand Synthesis System (Invitrogen, Carlsbad, CA). Four micro-
liters of each reaction was used for PCR analysis. For semiquantitative
analysis, a 50 μL PCR reaction was used to amplify gene fragments.
NbGDI2 primers were designed to amplify the endogenous gene
between nucleotides 300 and 700 using the following primers: NbGDI
300 FWD (CTTTAAAGCAGTTGATGGCAG) and NbGDI 700 REV
(GCTCTCCTAATCCATACAAAG). Four microliters of sample was re-
moved at the end of 27, 30, and 34 cycles. These samples were
visualized via agarose gel electrophoresis, photographed and ana-
lyzed for pixel density using an AlphaImager system (Alpha Innotech,
Santa Clara, CA). GDI ampliﬁed products were normalized to the EF1-
α internal standard and compared for differences in pixel density.
Transgene constructs, production of transgenic plants and analysis
The binary expression vector pBI121 (Clontech, Mountain View,
CA) was modiﬁed and used to express the following ORFs as GFP
fusions: GFP-HDEL (Haseloff et al., 1997), GFP-AtVam3 [AT5G46860]
(Uemura et al., 2002), AtSar1-GFP [AT1G56330] (daSilva et al., 2004),
AtPad1-GFP [AT3G51260] (Fu et al., 1998), AtERD2-GFP [AT1G29330].
A multi-cloning site (MCS) linker oligomer (5′-XbaI-XhoI-SpeI-SalI-
PacI-KpnI-HpaI-SacI-3′) was inserted into the XbaI and SstI sites of
pBI121. GFP-AtVam3 was constructed as an N-terminal GFP fusion
protein using the SpeI and PacI linker sites with the GFP ORF inserted
at the XhoI and SpeI sites. AtSar1-GFP, AtPad1-GFP, and AtERD2-GFP
were made as C-terminal GFP fusion proteins in a two-step process. In
the ﬁrst step AtSar1, AtPad1, and AtERD2 ORFs were PCR ampliﬁed to
contain 5′ XhoI and 3′ BsiWI restrictions sites. Each ORF was then
ligated downstream to the GFP ORF via the BsiWI site. In the second
step each fusion construct was moved into the modiﬁed pBI121 using
the XhoI and KpnI linker sites. The GFP-HDEL construct was made by
PCR amplifying the GFP ORF with C-terminal codons for the amino
acids HDEL and an N-terminal signal peptide as described by Horsch
et al. (1985). The PCR product was inserted into the modiﬁed pBI121
MCS using the XhoI and KpnI linker sites.
Surface sterilized leaf disks from N. benthamianawere cocultivated
with A. tumefaciens, strain GV 3101, carrying the modiﬁed pBI121
marker protein plasmids grown in LB media containing 25 μg/ml
gentamicin, 50 μg/ml rifampicin, and 50 μg/mL kanamycin. Trans-formed cells were selected for kanamycin resistance and regenerated
into plants as previously described (Horsch et al., 1985). Regenerated
plants were placed in soil and maintained in planter ﬂats with domes
to increase humidity for 2 weeks and gradually introduced to the
humidity of the growth chambers. All chambers were maintained at
23 °C with a 12-h photoperiod at 55% humidity.
Whole leaf and cell imaging
Whole leaves were removed from the plant and imaged using a
long wavelength UV lamp and a Tiffen™ 58 mm Yellow2 wavelength
ﬁlter on a Canon EOSD60 digital camera with a tripod. For confocal
imaging, leaf epidermal tissue was mounted using water and imaged
using a Zeiss LSM510 laser scanning confocal microscope system with
10× NA 0.8 dry and 63× NA 1.2 water-immersion lenses (Carl Zeiss
Inc., Thornwood, NY). Excitation sources were 488 nm for GFP and
543 nm for dsRed. Images were modiﬁed in Zeiss LSM Imager
Examiner and processed for printing in Adobe Photoshop CS (Grand
Prairie, TX).
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2010.12.030.
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